COVID-19 therapies: do we see substantial progress?

Matusewicz, Lucyna; Golec, Marlena; Czogalla, Aleksander; Kuliczkowski, Kazimierz; Konka, Adam; Zembala-John, Joanna; Sikorski, Aleksander F

Matusewicz, Lucyna; Golec, Marlena; Czogalla, Aleksander; Kuliczkowski, Kazimierz; Konka, Adam; Zembala-John, Joanna; Sikorski, Aleksander F.

Afiliación

Matusewicz L; Department of Cytobiochemistry, Faculty of Biotechnology, University of Wroclaw, ul. F. Joliot Curie 14a, 50-383, Wroclaw, Poland.
Golec M; Silesian Park of Medical Technology Kardio-Med Silesia, ul. M. Curie-Sklodowskiej 10c, 41-800, Zabrze, Poland.
Czogalla A; Department of Cytobiochemistry, Faculty of Biotechnology, University of Wroclaw, ul. F. Joliot Curie 14a, 50-383, Wroclaw, Poland.
Kuliczkowski K; Silesian Park of Medical Technology Kardio-Med Silesia, ul. M. Curie-Sklodowskiej 10c, 41-800, Zabrze, Poland.
Konka A; Silesian Park of Medical Technology Kardio-Med Silesia, ul. M. Curie-Sklodowskiej 10c, 41-800, Zabrze, Poland.
Zembala-John J; Chair and Department of Medicine and Environmental Epidemiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, H. Jordana 19, 41-800, Zabrze, Poland.
Sikorski AF; Acellmed Ltd., M. Curie-Sklodowskiej 10C, 41-800, Zabrze, Poland.

Cell Mol Biol Lett ; 27(1): 42, 2022 May 31.

Article en En | MEDLINE | ID: mdl-35641916

Asunto(s)

COVID-19; Humanos; SARS-CoV-2

Palabras clave

ACE2: coronaviruses; COVID-19; COVID-19 therapies; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Cell Mol Biol Lett Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google